ARS Pharmaceuticals Ownership 2024 | Who Owns ARS Pharmaceuticals Now?

Overview Forecast RevenueFinancials Chart

Institutional Ownership

100.00%

Insider Ownership

23.47%

Retail Ownership

-23.47%

Institutional Holders

87.00

ARS Pharmaceuticals Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)	27.73%	1.61%	11,077,927	-	-	72,117,305,000	Mar 31, 2023
ORBIMED ADVISORS LLC	21.88%	1.12%	8,740,887	-	-	56,903,174,000	Mar 31, 2023
FMR LLC	12.73%	0.00%	5,088,253	-281,109	-5.24%	33,124,526,000	Mar 31, 2023
SR ONE CAPITAL MANAGEMENT, LP	10.04%	9.73%	4,012,903	1,003,226	33.33%	26,123,999,000	Mar 31, 2023
RUBRIC CAPITAL MANAGEMENT LP	8.71%	0.59%	3,480,712	490,148	16.39%	22,659,435,000	Mar 31, 2023
RA CAPITAL MANAGEMENT, L.P.	7.53%	0.44%	3,009,678	-	-	19,593,004,000	Mar 31, 2023
K2 PRINCIPAL FUND, L.P.	6.72%	2.41%	2,686,490	-185,658	-6.46%	17,489,051,000	Mar 31, 2023
BAKER BROS. ADVISORS LP	5.02%	0.07%	2,006,451	-	-	13,061,996,000	Mar 31, 2023
NEXTECH INVEST LTD.	4.78%	5.19%	1,910,029	-	-	12,434,289,000	Mar 31, 2023
VANGUARD GROUP INC	4.25%	0.00%	1,697,637	9,717	0.58%	11,051,617,000	Mar 31, 2023
BLACKROCK INC.	2.80%	0.00%	1,118,565	215,020	23.80%	7,281,859,000	Mar 31, 2023
SECTORAL ASSET MANAGEMENT INC	1.99%	0.99%	793,587	11,177	1.43%	5,166,251,000	Mar 31, 2023
NICHOLAS INVESTMENT PARTNERS, LP	1.89%	0.37%	755,622	755,622	100.00%	4,919,099,000	Mar 31, 2023
WOODLINE PARTNERS LP	1.50%	0.05%	600,000	-661,307	-52.43%	3,906,000,000	Mar 31, 2023
TANG CAPITAL MANAGEMENT LLC	1.02%	0.40%	409,463	-	-	2,665,604,000	Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	1.01%	0.00%	403,604	71,408	21.50%	2,627,462,000	Mar 31, 2023
DIMENSIONAL FUND ADVISORS LP	0.84%	0.00%	334,259	166	0.05%	2,176,026,000	Mar 31, 2023
RENAISSANCE TECHNOLOGIES LLC	0.83%	0.00%	330,600	19,600	6.30%	2,152,000	Mar 31, 2023
SUSQUEHANNA INTERNATIONAL GROUP, LLP	0.78%	0.00%	312,954	267,008	581.13%	2,037,331,000	Mar 31, 2023
ROYCE & ASSOCIATES LP	0.76%	0.02%	303,900	303,900	100.00%	1,978,389,000	Mar 31, 2023

ARS Pharmaceuticals's largest institutional shareholder is DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), holding 27.73% of the company's total share outstanding, currently valued at $72.12B. The top 10 institutional shareholders own together 109.40% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
SR ONE CAPITAL MANAGEMENT, LP	10.04%	9.73%	4,012,903	1,003,226	33.33%	26,123,999,000	Mar 31, 2023
NEXTECH INVEST LTD.	4.78%	5.19%	1,910,029	-	-	12,434,289,000	Mar 31, 2023
K2 PRINCIPAL FUND, L.P.	6.72%	2.41%	2,686,490	-185,658	-6.46%	17,489,051,000	Mar 31, 2023
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)	27.73%	1.61%	11,077,927	-	-	72,117,305,000	Mar 31, 2023
ORBIMED ADVISORS LLC	21.88%	1.12%	8,740,887	-	-	56,903,174,000	Mar 31, 2023
SECTORAL ASSET MANAGEMENT INC	1.99%	0.99%	793,587	11,177	1.43%	5,166,251,000	Mar 31, 2023
TEJARA CAPITAL LTD	0.52%	0.69%	207,555	172,800	497.19%	1,351,183,000	Mar 31, 2023
RUBRIC CAPITAL MANAGEMENT LP	8.71%	0.59%	3,480,712	490,148	16.39%	22,659,435,000	Mar 31, 2023
RESOLUTE CAPITAL ASSET PARTNERS LLC	0.30%	0.57%	120,000	120,000	100.00%	781,000	Mar 31, 2023
RA CAPITAL MANAGEMENT, L.P.	7.53%	0.44%	3,009,678	-	-	19,593,004,000	Mar 31, 2023
TANG CAPITAL MANAGEMENT LLC	1.02%	0.40%	409,463	-	-	2,665,604,000	Mar 31, 2023
NICHOLAS INVESTMENT PARTNERS, LP	1.89%	0.37%	755,622	755,622	100.00%	4,919,099,000	Mar 31, 2023
EAM INVESTORS, LLC	0.03%	0.27%	9,989	-114,784	-91.99%	1,208,377,000	Mar 31, 2023
LEVIN CAPITAL STRATEGIES, L.P.	0.35%	0.11%	140,351	101,341	259.78%	913,685,000	Mar 31, 2023
K2 PRINCIPAL FUND, L.P.	0.28%	0.10%	111,600	111,600	100.00%	726,516,000	Mar 31, 2023
BAKER BROS. ADVISORS LP	5.02%	0.07%	2,006,451	-	-	13,061,996,000	Mar 31, 2023
WOODLINE PARTNERS LP	1.50%	0.05%	600,000	-661,307	-52.43%	3,906,000,000	Mar 31, 2023
UBS OCONNOR LLC	0.38%	0.04%	149,915	149,915	100.00%	975,947,000,000	Mar 31, 2023
CAXTON ASSOCIATES LP	0.11%	0.04%	43,169	28,337	191.05%	281,030,000	Mar 31, 2023
DIAMETRIC CAPITAL, LP	0.03%	0.04%	13,157	13,157	100.00%	85,652,000	Mar 31, 2023

The largest ARS Pharmaceuticals shareholder by % of total assets is SR ONE CAPITAL MANAGEMENT, LP. The company owns 4.01M shares of ARS Pharmaceuticals (SPRY), representing 9.73% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
SR ONE CAPITAL MANAGEMENT, LP	10.04%	9.73%	4,012,903	1,003,226	33.33%	26,123,999,000	Mar 31, 2023
NICHOLAS INVESTMENT PARTNERS, LP	1.89%	0.37%	755,622	755,622	100.00%	4,919,099,000	Mar 31, 2023
RUBRIC CAPITAL MANAGEMENT LP	8.71%	0.59%	3,480,712	490,148	16.39%	22,659,435,000	Mar 31, 2023
ROYCE & ASSOCIATES LP	0.76%	0.02%	303,900	303,900	100.00%	1,978,389,000	Mar 31, 2023
SUSQUEHANNA INTERNATIONAL GROUP, LLP	0.78%	0.00%	312,954	267,008	581.13%	2,037,331,000	Mar 31, 2023
AMERIPRISE FINANCIAL INC	0.70%	0.00%	280,329	244,919	691.67%	1,824,942,000	Mar 31, 2023
MILLENNIUM MANAGEMENT LLC	0.62%	0.00%	249,412	217,711	686.76%	1,624,000	Mar 31, 2023
BLACKROCK INC.	2.80%	0.00%	1,118,565	215,020	23.80%	7,281,859,000	Mar 31, 2023
KENNEDY CAPITAL MANAGEMENT LLC	0.46%	0.04%	183,287	183,287	100.00%	1,193,198,000	Mar 31, 2023
TEJARA CAPITAL LTD	0.52%	0.69%	207,555	172,800	497.19%	1,351,183,000	Mar 31, 2023
UBS OCONNOR LLC	0.38%	0.04%	149,915	149,915	100.00%	975,947,000,000	Mar 31, 2023
HRT FINANCIAL LP	0.34%	0.01%	135,684	135,684	100.00%	883,000	Mar 31, 2023
RESOLUTE CAPITAL ASSET PARTNERS LLC	0.30%	0.57%	120,000	120,000	100.00%	781,000	Mar 31, 2023
JANE STREET GROUP, LLC	0.34%	0.00%	137,450	117,793	599.24%	894,800,000	Mar 31, 2023
K2 PRINCIPAL FUND, L.P.	0.28%	0.10%	111,600	111,600	100.00%	726,516,000	Mar 31, 2023
LEVIN CAPITAL STRATEGIES, L.P.	0.35%	0.11%	140,351	101,341	259.78%	913,685,000	Mar 31, 2023
GOLDMAN SACHS GROUP INC	0.49%	0.00%	196,504	83,609	74.06%	1,279,241,000	Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	1.01%	0.00%	403,604	71,408	21.50%	2,627,462,000	Mar 31, 2023
LEGAL & GENERAL GROUP PLC	0.16%	0.00%	64,543	64,543	100.00%	420,175,000	Mar 31, 2023
INVESCO LTD.	0.62%	0.00%	246,989	56,127	29.41%	1,607,898,000	Mar 31, 2023

As of Mar 31 2023, ARS Pharmaceuticals's largest institutional buyer is SR ONE CAPITAL MANAGEMENT, LP. The company purchased 1.00M stocks of SPRY, valued at $26.12B.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
WOODLINE PARTNERS LP	1.50%	0.05%	600,000	-661,307	-52.43%	3,906,000,000	Mar 31, 2023
OASIS MANAGEMENT CO LTD.	-	-	-	-317,662	-100.00%	-	Mar 31, 2023
FMR LLC	12.73%	0.00%	5,088,253	-281,109	-5.24%	33,124,526,000	Mar 31, 2023
K2 PRINCIPAL FUND, L.P.	6.72%	2.41%	2,686,490	-185,658	-6.46%	17,489,051,000	Mar 31, 2023
EAM GLOBAL INVESTORS LLC	-	-	-	-183,452	-100.00%	-	Mar 31, 2023
NEW YORK LIFE INVESTMENT MANAGEMENT LLC	-	-	-	-161,617	-100.00%	-	Mar 31, 2023
EAM INVESTORS, LLC	0.03%	0.27%	9,989	-114,784	-91.99%	1,208,377,000	Mar 31, 2023
BRIDGEWAY CAPITAL MANAGEMENT, LLC	0.05%	0.00%	19,944	-69,500	-77.70%	129,835,000	Mar 31, 2023
CITIGROUP INC	0.13%	0.00%	53,381	-41,633	-43.82%	347,510,000	Mar 31, 2023
CUBIST SYSTEMATIC STRATEGIES, LLC	0.09%	0.00%	35,114	-28,966	-45.20%	228,592,000	Mar 31, 2023
TWO SIGMA ADVISERS, LP	0.55%	0.00%	220,800	-23,300	-9.55%	1,437,408,000	Mar 31, 2023
ALGERT GLOBAL LLC	-	-	-	-19,920	-100.00%	-	Mar 31, 2023
D. E. SHAW & CO., INC.	0.06%	0.00%	24,302	-19,396	-44.39%	158,206,000	Mar 31, 2023
RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC.	-	-	-	-16,742	-100.00%	-	Mar 31, 2023
BALYASNY ASSET MANAGEMENT L.P.	-	-	-	-11,328	-100.00%	-	Mar 31, 2023
MIRABELLA FINANCIAL SERVICES LLP	-	-	-	-10,573	-100.00%	-	Mar 31, 2023
CANNELL CAPITAL LLC	-	-	-	-9,402	-100.00%	-	Mar 31, 2023
683 CAPITAL MANAGEMENT, LLC	0.05%	0.01%	21,500	-4,554	-17.48%	139,965,000	Mar 31, 2023
JANNEY MONTGOMERY SCOTT LLC	0.13%	0.00%	50,243	-3,471	-6.46%	327,000	Mar 31, 2023
JACOBS LEVY EQUITY MANAGEMENT, INC	0.74%	0.01%	295,271	-3,345	-1.12%	1,922,214,000	Mar 31, 2023

As of Mar 31 2023, ARS Pharmaceuticals's biggest institutional seller is WOODLINE PARTNERS LP. The company sold -0.66M shares of SPRY, valued at $3.91B.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
NICHOLAS INVESTMENT PARTNERS, LP	1.89%	0.37%	755,622	755,622	100.00%	4,919,099,000	Mar 31, 2023
ROYCE & ASSOCIATES LP	0.76%	0.02%	303,900	303,900	100.00%	1,978,389,000	Mar 31, 2023
KENNEDY CAPITAL MANAGEMENT LLC	0.46%	0.04%	183,287	183,287	100.00%	1,193,198,000	Mar 31, 2023
UBS OCONNOR LLC	0.38%	0.04%	149,915	149,915	100.00%	975,947,000,000	Mar 31, 2023
HRT FINANCIAL LP	0.34%	0.01%	135,684	135,684	100.00%	883,000	Mar 31, 2023
RESOLUTE CAPITAL ASSET PARTNERS LLC	0.30%	0.57%	120,000	120,000	100.00%	781,000	Mar 31, 2023
K2 PRINCIPAL FUND, L.P.	0.28%	0.10%	111,600	111,600	100.00%	726,516,000	Mar 31, 2023
LEGAL & GENERAL GROUP PLC	0.16%	0.00%	64,543	64,543	100.00%	420,175,000	Mar 31, 2023
AMERICAN CENTURY COMPANIES INC	0.10%	-	39,132	39,132	100.00%	51,434,000	Mar 31, 2023
VERITION FUND MANAGEMENT LLC	0.06%	0.00%	23,869	23,869	100.00%	155,387,000	Mar 31, 2023
LMR PARTNERS LLP	0.05%	0.00%	21,207	21,207	100.00%	138,058,000	Mar 31, 2023
K2 PRINCIPAL FUND, L.P.	0.04%	0.02%	17,800	17,800	100.00%	115,878,000	Mar 31, 2023
SUSQUEHANNA INTERNATIONAL GROUP, LLP	0.04%	-	14,000	14,000	100.00%	91,140,000	Mar 31, 2023
DIAMETRIC CAPITAL, LP	0.03%	0.04%	13,157	13,157	100.00%	85,652,000	Mar 31, 2023
SQUAREPOINT OPS LLC	0.03%	0.00%	12,903	12,903	100.00%	83,999,000	Mar 31, 2023
DYNAMIC TECHNOLOGY LAB PRIVATE LTD	0.03%	0.01%	12,067	12,067	100.00%	79,000	Mar 31, 2023
PRICE T ROWE ASSOCIATES INC /MD/	0.03%	-	11,601	11,601	100.00%	76,000	Mar 31, 2023
HIGHTOWER ADVISORS, LLC	0.03%	0.00%	11,000	11,000	100.00%	72,000,000	Mar 31, 2023
NATIONS FINANCIAL GROUP INC, /IA/ /ADV	0.03%	0.01%	11,000	11,000	100.00%	71,610,000	Mar 31, 2023
GSA CAPITAL PARTNERS LLP	0.03%	0.01%	10,744	10,744	100.00%	70,000	Mar 31, 2023
VIRTU FINANCIAL LLC	0.03%	0.01%	10,411	10,411	100.00%	68,000	Mar 31, 2023
POINT72 ASSET MANAGEMENT, L.P.	0.01%	0.00%	5,238	5,238	100.00%	34,099,000	Mar 31, 2023
POINT72 MIDDLE EAST FZE	0.01%	0.00%	5,011	5,011	100.00%	32,622,000	Mar 31, 2023
UBS GROUP AG	0.01%	-	2,903	2,903	100.00%	18,898,000	Mar 31, 2023
ZURCHER KANTONALBANK (ZURICH CANTONALBANK)	0.01%	0.00%	2,850	2,850	100.00%	18,554,000	Mar 31, 2023
CITADEL ADVISORS LLC	0.01%	-	2,200	2,200	100.00%	14,322,000	Mar 31, 2023
STEWARD PARTNERS INVESTMENT ADVISORY, LLC	0.00%	0.00%	1,200	1,200	100.00%	7,812,000	Mar 31, 2023
DAIWA SECURITIES GROUP INC.	0.00%	-	367	367	100.00%	2,000	Mar 31, 2023
TCI WEALTH ADVISORS, INC.	0.00%	0.00%	240	240	100.00%	1,563,000	Mar 31, 2023

ARS Pharmaceuticals's largest new institutional shareholder by number of shares is NICHOLAS INVESTMENT PARTNERS, LP, purchased 755.62K shares, valued at $4.92B, as of undefined.

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
OASIS MANAGEMENT CO LTD.	-	-	-	-317,662	-100.00%	-	Mar 31, 2023
EAM GLOBAL INVESTORS LLC	-	-	-	-183,452	-100.00%	-	Mar 31, 2023
NEW YORK LIFE INVESTMENT MANAGEMENT LLC	-	-	-	-161,617	-100.00%	-	Mar 31, 2023
ALGERT GLOBAL LLC	-	-	-	-19,920	-100.00%	-	Mar 31, 2023
RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC.	-	-	-	-16,742	-100.00%	-	Mar 31, 2023
BALYASNY ASSET MANAGEMENT L.P.	-	-	-	-11,328	-100.00%	-	Mar 31, 2023
MIRABELLA FINANCIAL SERVICES LLP	-	-	-	-10,573	-100.00%	-	Mar 31, 2023
CANNELL CAPITAL LLC	-	-	-	-9,402	-100.00%	-	Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.	-	-	-	-2,000	-100.00%	-	Mar 31, 2023

ARS Pharmaceuticals's largest sold out institutional shareholder by shares sold is OASIS MANAGEMENT CO LTD., sold -0.32M shares, valued at -, as of undefined.

ARS Pharmaceuticals Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
BRIDGEWAY FUNDS INC	0.01%	13,644	-	-	Dec 29, 2023

ARS Pharmaceuticals's largest mutual fund holder by % of total assets is "BRIDGEWAY FUNDS INC", owning 13.64K shares, compromising 0.01% of its total assets.

ARS Pharmaceuticals Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
31 Mar, 23	87	22.54%
31 Dec, 22	71	-
31 Dec, 21	-	-100.00%
30 Sep, 21	2	-
30 Jun, 21	2	-
31 Mar, 21	2	-

As of 31 Mar 23, 87 institutions are holding ARS Pharmaceuticals's shares, representing an increase of 22.54% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
31 Mar, 23	53,205,891	6.13%
31 Dec, 22	50,132,302	-
31 Dec, 21	-	-100.00%
30 Sep, 21	15,481	63.84%
30 Jun, 21	9,449	-1.21%
31 Mar, 21	9,565	-

ARS Pharmaceuticals (SPRY) has 53.21M shares outstanding as of 31 Mar 23, up 6.13% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
31 Mar, 23	100.00%	-
31 Dec, 22	100.00%	-
31 Dec, 21	-	-100.00%
30 Sep, 21	0.04%	63.24%
30 Jun, 21	0.03%	-91.73%
31 Mar, 21	0.33%	-

As of 31 Mar 23, ARS Pharmaceuticals is held by 100.00% institutional shareholders, representing a 0.00% growth compared to 31 Dec 22.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
31 Mar, 23	34	-27.66%
31 Dec, 22	47	-
31 Dec, 21	-	-
30 Sep, 21	-	-
30 Jun, 21	-	-
31 Mar, 21	-	-

34 institutional shareholders have increased their position in SPRY stock as of 31 Mar 23 compared to 47 in the previous quarter (a -27.66% decrease).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
31 Mar, 23	17	-
31 Dec, 22	-	-
31 Dec, 21	-	-
30 Sep, 21	-	-
30 Jun, 21	-	-
31 Mar, 21	-	-

17 institutional shareholders have reduced their position in SPRY stock as of 31 Mar 23 compared to - in the previous quarter (a 0.00% increase).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
31 Mar, 23	87	22.54%	53,205,891	6.13%	100.00%	-	34	-27.66%	17	-
31 Dec, 22	71	-	50,132,302	-	100.00%	-	47	-	-	-
31 Dec, 21	-	-100.00%	-	-100.00%	-	-100.00%	-	-	-	-
30 Sep, 21	2	-	15,481	63.84%	0.04%	63.24%	-	-	-	-
30 Jun, 21	2	-	9,449	-1.21%	0.03%	-91.73%	-	-	-	-
31 Mar, 21	2	-	9,565	-	0.33%	-	-	-	-	-

ARS Pharmaceuticals Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
May 16, 2024	Tanimoto Sarina	10 percent owner, officer	CHIEF MEDICAL OFFICER	S-Sale	Sell	2,884	$9.01	$25.97K	1,795,615
May 16, 2024	Tanimoto Sarina	10 percent owner, officer	CHIEF MEDICAL OFFICER	S-Sale	Sell	2,766	$9.04	$25.01K	1,792,849
May 16, 2024	Tanimoto Sarina	10 percent owner, officer	CHIEF MEDICAL OFFICER	S-Sale	Sell	44,350	$9.06	$401.71K	1,748,499
May 16, 2024	Tanimoto Sarina	10 percent owner, officer	CHIEF MEDICAL OFFICER	S-Sale	Sell	2,873	$9.01	$25.88K	1,644,574
May 16, 2024	Tanimoto Sarina	10 percent owner, officer	CHIEF MEDICAL OFFICER	S-Sale	Sell	2,381	$9.05	$21.56K	1,642,193
May 16, 2024	Tanimoto Sarina	10 percent owner, officer	CHIEF MEDICAL OFFICER	S-Sale	Sell	44,746	$9.06	$405.31K	1,597,447
May 16, 2024	Lowenthal Richard E	director, 10 percent owner, officer	PRESIDENT AND CEO	S-Sale	Sell	2,884	$9.01	$25.97K	1,795,615
May 16, 2024	Lowenthal Richard E	director, 10 percent owner, officer	PRESIDENT AND CEO	S-Sale	Sell	2,766	$9.04	$25.01K	1,792,849
May 16, 2024	Lowenthal Richard E	director, 10 percent owner, officer	PRESIDENT AND CEO	S-Sale	Sell	44,350	$9.06	$401.71K	1,748,499
May 16, 2024	Lowenthal Richard E	director, 10 percent owner, officer	PRESIDENT AND CEO	S-Sale	Sell	2,873	$9.01	$25.88K	1,644,574
May 16, 2024	Lowenthal Richard E	director, 10 percent owner, officer	PRESIDENT AND CEO	S-Sale	Sell	2,381	$9.05	$21.56K	1,642,193
May 16, 2024	Lowenthal Richard E	director, 10 percent owner, officer	PRESIDENT AND CEO	S-Sale	Sell	44,746	$9.06	$405.31K	1,597,447
May 09, 2024	Tanimoto Sarina	10 percent owner, officer	CHIEF MEDICAL OFFICER	S-Sale	Sell	50,000	$9.34	$467.23K	1,798,499
May 09, 2024	Tanimoto Sarina	10 percent owner, officer	CHIEF MEDICAL OFFICER	S-Sale	Sell	50,000	$9.34	$467.14K	1,596,494
May 09, 2024	Lowenthal Richard E	director, 10 percent owner, officer	PRESIDENT AND CEO	S-Sale	Sell	50,000	$9.34	$467.23K	1,798,499
May 09, 2024	Lowenthal Richard E	director, 10 percent owner, officer	PRESIDENT AND CEO	S-Sale	Sell	50,000	$9.34	$467.14K	1,596,494

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
May 16, 2024	Tanimoto Sarina	10 percent owner, officer	CHIEF MEDICAL OFFICER	S-Sale	Sell	2,884	$9.01	$25.97K	1,795,615
May 16, 2024	Tanimoto Sarina	10 percent owner, officer	CHIEF MEDICAL OFFICER	S-Sale	Sell	2,766	$9.04	$25.01K	1,792,849
May 16, 2024	Tanimoto Sarina	10 percent owner, officer	CHIEF MEDICAL OFFICER	S-Sale	Sell	44,350	$9.06	$401.71K	1,748,499
May 16, 2024	Tanimoto Sarina	10 percent owner, officer	CHIEF MEDICAL OFFICER	S-Sale	Sell	2,873	$9.01	$25.88K	1,644,574
May 16, 2024	Tanimoto Sarina	10 percent owner, officer	CHIEF MEDICAL OFFICER	S-Sale	Sell	2,381	$9.05	$21.56K	1,642,193
May 16, 2024	Tanimoto Sarina	10 percent owner, officer	CHIEF MEDICAL OFFICER	S-Sale	Sell	44,746	$9.06	$405.31K	1,597,447
May 16, 2024	Lowenthal Richard E	director, 10 percent owner, officer	PRESIDENT AND CEO	S-Sale	Sell	2,884	$9.01	$25.97K	1,795,615
May 16, 2024	Lowenthal Richard E	director, 10 percent owner, officer	PRESIDENT AND CEO	S-Sale	Sell	2,766	$9.04	$25.01K	1,792,849
May 16, 2024	Lowenthal Richard E	director, 10 percent owner, officer	PRESIDENT AND CEO	S-Sale	Sell	44,350	$9.06	$401.71K	1,748,499
May 16, 2024	Lowenthal Richard E	director, 10 percent owner, officer	PRESIDENT AND CEO	S-Sale	Sell	2,873	$9.01	$25.88K	1,644,574
May 16, 2024	Lowenthal Richard E	director, 10 percent owner, officer	PRESIDENT AND CEO	S-Sale	Sell	2,381	$9.05	$21.56K	1,642,193
May 16, 2024	Lowenthal Richard E	director, 10 percent owner, officer	PRESIDENT AND CEO	S-Sale	Sell	44,746	$9.06	$405.31K	1,597,447
May 09, 2024	Tanimoto Sarina	10 percent owner, officer	CHIEF MEDICAL OFFICER	S-Sale	Sell	50,000	$9.34	$467.23K	1,798,499
May 09, 2024	Tanimoto Sarina	10 percent owner, officer	CHIEF MEDICAL OFFICER	S-Sale	Sell	50,000	$9.34	$467.14K	1,596,494
May 09, 2024	Lowenthal Richard E	director, 10 percent owner, officer	PRESIDENT AND CEO	S-Sale	Sell	50,000	$9.34	$467.23K	1,798,499
May 09, 2024	Lowenthal Richard E	director, 10 percent owner, officer	PRESIDENT AND CEO	S-Sale	Sell	50,000	$9.34	$467.14K	1,596,494
Apr 24, 2024	Tanimoto Sarina	10 percent owner, officer	CHIEF MEDICAL OFFICER	M-Exempt	Sell	48,260	$1.44	$69.49K	34,473
Apr 24, 2024	Tanimoto Sarina	10 percent owner, officer	CHIEF MEDICAL OFFICER	M-Exempt	Sell	82,733	$0.84	$69.50K	-

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
May 16, 2024	Tanimoto Sarina	10 percent owner, officer	CHIEF MEDICAL OFFICER	S-Sale	Sell	2,884	$9.01	$25.97K	1,795,615
May 16, 2024	Tanimoto Sarina	10 percent owner, officer	CHIEF MEDICAL OFFICER	S-Sale	Sell	2,766	$9.04	$25.01K	1,792,849
May 16, 2024	Tanimoto Sarina	10 percent owner, officer	CHIEF MEDICAL OFFICER	S-Sale	Sell	44,350	$9.06	$401.71K	1,748,499
May 16, 2024	Tanimoto Sarina	10 percent owner, officer	CHIEF MEDICAL OFFICER	S-Sale	Sell	2,873	$9.01	$25.88K	1,644,574
May 16, 2024	Tanimoto Sarina	10 percent owner, officer	CHIEF MEDICAL OFFICER	S-Sale	Sell	2,381	$9.05	$21.56K	1,642,193
May 16, 2024	Tanimoto Sarina	10 percent owner, officer	CHIEF MEDICAL OFFICER	S-Sale	Sell	44,746	$9.06	$405.31K	1,597,447
May 16, 2024	Lowenthal Richard E	director, 10 percent owner, officer	PRESIDENT AND CEO	S-Sale	Sell	2,884	$9.01	$25.97K	1,795,615
May 16, 2024	Lowenthal Richard E	director, 10 percent owner, officer	PRESIDENT AND CEO	S-Sale	Sell	2,766	$9.04	$25.01K	1,792,849
May 16, 2024	Lowenthal Richard E	director, 10 percent owner, officer	PRESIDENT AND CEO	S-Sale	Sell	44,350	$9.06	$401.71K	1,748,499
May 16, 2024	Lowenthal Richard E	director, 10 percent owner, officer	PRESIDENT AND CEO	S-Sale	Sell	2,873	$9.01	$25.88K	1,644,574
May 16, 2024	Lowenthal Richard E	director, 10 percent owner, officer	PRESIDENT AND CEO	S-Sale	Sell	2,381	$9.05	$21.56K	1,642,193
May 16, 2024	Lowenthal Richard E	director, 10 percent owner, officer	PRESIDENT AND CEO	S-Sale	Sell	44,746	$9.06	$405.31K	1,597,447
May 09, 2024	Tanimoto Sarina	10 percent owner, officer	CHIEF MEDICAL OFFICER	S-Sale	Sell	50,000	$9.34	$467.23K	1,798,499
May 09, 2024	Tanimoto Sarina	10 percent owner, officer	CHIEF MEDICAL OFFICER	S-Sale	Sell	50,000	$9.34	$467.14K	1,596,494
May 09, 2024	Lowenthal Richard E	director, 10 percent owner, officer	PRESIDENT AND CEO	S-Sale	Sell	50,000	$9.34	$467.23K	1,798,499
May 09, 2024	Lowenthal Richard E	director, 10 percent owner, officer	PRESIDENT AND CEO	S-Sale	Sell	50,000	$9.34	$467.14K	1,596,494
Apr 24, 2024	Tanimoto Sarina	10 percent owner, officer	CHIEF MEDICAL OFFICER	M-Exempt	Buy	48,260	$1.44	$69.49K	3,407,847
Apr 24, 2024	Tanimoto Sarina	10 percent owner, officer	CHIEF MEDICAL OFFICER	M-Exempt	Buy	82,733	$0.84	$69.50K	3,359,587
Apr 24, 2024	Tanimoto Sarina	10 percent owner, officer	CHIEF MEDICAL OFFICER	M-Exempt	Sell	48,260	$1.44	$69.49K	34,473
Apr 24, 2024	Tanimoto Sarina	10 percent owner, officer	CHIEF MEDICAL OFFICER	M-Exempt	Sell	82,733	$0.84	$69.50K	-

The last insider sell of ARS Pharmaceuticals's stock was made by Tanimoto Sarina on May 16 2024, selling 2,884 shares at $9.01 per share (valued at $25.97K).

ARS Pharmaceuticals Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q2 2024	8	32	25.00%
Q1 2024	12	44	27.27%
Q3 2023	17	19	89.47%
Q2 2023	17	12	141.67%
Q1 2023	9	-	-
Q4 2022	2	1	200.00%
Q1 2015	-	1	-

8 total buy trades, and 32 total sell trades (buy/sell ratio of 0.25%) were made by ARS Pharmaceuticals's insiders, as of Q2 2024.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q2 2024	-	24	-
Q1 2024	3	44	6.82%
Q3 2023	7	9	77.78%
Q2 2023	-	4	-
Q1 2023	-	-	-
Q4 2022	-	1	-
Q1 2015	-	-	-

As of Q2 2024, Insider owners conducted 0 open market buy trades and 24 open market sell trades of ARS Pharmaceuticals's stocks.

ARS Pharmaceuticals Peer Ownership

Ticker	Company
ZURA	Zura Bio Limited
CNSP	CNS Pharmaceuticals, Inc.
TFFP	TFF Pharmaceuticals, Inc.
TCRX	TScan Therapeutics, Inc.
CFRX	ContraFect Corporation
PALI	Palisade Bio, Inc.
INAB	IN8bio, Inc.
IMMX	Immix Biopharma, Inc.
WVE	Wave Life Sciences Ltd.
ANNX	Annexon, Inc.
CUE	Cue Biopharma, Inc.
WINT	Windtree Therapeutics, Inc.
ALLR	Allarity Therapeutics, Inc.
AVRO	AVROBIO, Inc.
DRMA	Dermata Therapeutics, Inc.
CGTX	Cognition Therapeutics, Inc.
HEPA	Hepion Pharmaceuticals, Inc.

SPRY Ownership FAQ

Who Owns ARS Pharmaceuticals?

ARS Pharmaceuticals is owned by institutional shareholders (100.00%), insiders (23.47%), and public (-23.47%). The largest institutional shareholder of ARS Pharmaceuticals is DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (27.73% of total shares) and the top mutual fund owner is BRIDGEWAY FUNDS INC (0.01% of total shares).

Who are the major institutional shareholders of ARS Pharmaceuticals?

ARS Pharmaceuticals's major institutional shareholders are DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), ORBIMED ADVISORS LLC, FMR LLC, SR ONE CAPITAL MANAGEMENT, LP, and RUBRIC CAPITAL MANAGEMENT LP. The top five shareholders own together 81.09% of the company's share outstanding.

How many ARS Pharmaceuticals shareholders are there?

As of Mar 2023, there are 87 institutional shareholders of ARS Pharmaceuticals.

What percentage of ARS Pharmaceuticals is owned by DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)?

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) owns 11.08M shares of ARS Pharmaceuticals, representing 27.73% of the company's total shares outstanding, valued at $72.12B (as of Mar 2023).

What percentage of ARS Pharmaceuticals is owned by ORBIMED ADVISORS LLC?

As of Mar 2023, ORBIMED ADVISORS LLC holds 8.74M shares of ARS Pharmaceuticals (SPRY), compromising 21.88% of the company, valued at $56.9B.

What percentage of ARS Pharmaceuticals is owned by FMR LLC?

FMR LLC is the third largest holder of ARS Pharmaceuticals. The company owns 5.09M of the company's shares outstanding (worth $33.12B).